Creative Medical Technology Holdings, Inc., was incorporated in Nevada on December 3, 1998. The company is a commercial-stage biotechnology company dedicated to advancing regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. 

Creative Medical shares surge 13.66% premarket on positive ADAPT trial data showing durable efficacy and safety for CELZ-201 in chronic back pain.

Creative Medical shares surge 10.73% intraday after positive interim ADAPT trial data for CELZ-201 in chronic lower back pain, marking a major clinical inflection point.

创意医疗科技控股

Creative Medical Reports Positive Interim Data for CELZ-201 Olastrocel

Creative Medical

Creative Medical Technology Holdings Achieves Major Clinical Milestone with Positive ADAPT Trial Data and Demonstrates Promising Safety Profile for CELZ-201 (Olastrocel) in Chronic Lower Back Pain Treatment.

CELZ News